Cargando…
Making (anti-) sense out of huntingtin levels in Huntington disease
BACKGROUND: Huntington disease (HD) is an autosomal dominant neurodegenerative disorder, characterized by motor, psychiatric and cognitive symptoms. HD is caused by a CAG repeat expansion in the first exon of the HTT gene, resulting in an expanded polyglutamine tract at the N-terminus of the hunting...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411791/ https://www.ncbi.nlm.nih.gov/pubmed/25928884 http://dx.doi.org/10.1186/s13024-015-0018-7 |
_version_ | 1782368543072845824 |
---|---|
author | Evers, Melvin M Schut, Menno H Pepers, Barry A Atalar, Melek van Belzen, Martine J Faull, Richard LM Roos, Raymund AC van Roon-Mom, Willeke MC |
author_facet | Evers, Melvin M Schut, Menno H Pepers, Barry A Atalar, Melek van Belzen, Martine J Faull, Richard LM Roos, Raymund AC van Roon-Mom, Willeke MC |
author_sort | Evers, Melvin M |
collection | PubMed |
description | BACKGROUND: Huntington disease (HD) is an autosomal dominant neurodegenerative disorder, characterized by motor, psychiatric and cognitive symptoms. HD is caused by a CAG repeat expansion in the first exon of the HTT gene, resulting in an expanded polyglutamine tract at the N-terminus of the huntingtin protein. Typical disease onset is around mid-life (adult-onset HD) whereas onset below 21 years is classified as juvenile HD. While much research has been done on the underlying HD disease mechanisms, little is known about regulation and expression levels of huntingtin RNA and protein. RESULTS: In this study we used 15 human post-mortem HD brain samples to investigate the expression of wild-type and mutant huntingtin mRNA and protein. In adult-onset HD brain samples, there was a small but significantly lower expression of mutant huntingtin mRNA compared to wild-type huntingtin mRNA, while wild-type and mutant huntingtin protein expression levels did not differ significantly. Juvenile HD subjects did show a lower expression of mutant huntingtin protein compared to wild-type huntingtin protein. Our results in HD brain and fibroblasts suggest that protein aggregation does not affect levels of huntingtin RNA and protein. Additionally, we did not find any evidence for a reduced expression of huntingtin antisense in fibroblasts derived from a homozygous HD patient. CONCLUSIONS: We found small differences in allelic huntingtin mRNA levels in adult-onset HD brain, with significantly lower mutant huntingtin mRNA levels. Wild-type and mutant huntingtin protein were not significantly different in adult-onset HD brain samples. Conversely, in juvenile HD brain samples mutant huntingtin protein levels were lower compared with wild-type huntingtin, showing subtle differences between juvenile HD and adult-onset HD. Since most HD model systems harbor juvenile repeat expansions, our results suggest caution with the interpretation of huntingtin mRNA and protein studies using HD cell and animal models with such long repeats. Furthermore, our huntingtin antisense results in homozygous HD cells do not support reduced huntingtin antisense expression due to an expanded CAG repeat. |
format | Online Article Text |
id | pubmed-4411791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44117912015-04-29 Making (anti-) sense out of huntingtin levels in Huntington disease Evers, Melvin M Schut, Menno H Pepers, Barry A Atalar, Melek van Belzen, Martine J Faull, Richard LM Roos, Raymund AC van Roon-Mom, Willeke MC Mol Neurodegener Research Article BACKGROUND: Huntington disease (HD) is an autosomal dominant neurodegenerative disorder, characterized by motor, psychiatric and cognitive symptoms. HD is caused by a CAG repeat expansion in the first exon of the HTT gene, resulting in an expanded polyglutamine tract at the N-terminus of the huntingtin protein. Typical disease onset is around mid-life (adult-onset HD) whereas onset below 21 years is classified as juvenile HD. While much research has been done on the underlying HD disease mechanisms, little is known about regulation and expression levels of huntingtin RNA and protein. RESULTS: In this study we used 15 human post-mortem HD brain samples to investigate the expression of wild-type and mutant huntingtin mRNA and protein. In adult-onset HD brain samples, there was a small but significantly lower expression of mutant huntingtin mRNA compared to wild-type huntingtin mRNA, while wild-type and mutant huntingtin protein expression levels did not differ significantly. Juvenile HD subjects did show a lower expression of mutant huntingtin protein compared to wild-type huntingtin protein. Our results in HD brain and fibroblasts suggest that protein aggregation does not affect levels of huntingtin RNA and protein. Additionally, we did not find any evidence for a reduced expression of huntingtin antisense in fibroblasts derived from a homozygous HD patient. CONCLUSIONS: We found small differences in allelic huntingtin mRNA levels in adult-onset HD brain, with significantly lower mutant huntingtin mRNA levels. Wild-type and mutant huntingtin protein were not significantly different in adult-onset HD brain samples. Conversely, in juvenile HD brain samples mutant huntingtin protein levels were lower compared with wild-type huntingtin, showing subtle differences between juvenile HD and adult-onset HD. Since most HD model systems harbor juvenile repeat expansions, our results suggest caution with the interpretation of huntingtin mRNA and protein studies using HD cell and animal models with such long repeats. Furthermore, our huntingtin antisense results in homozygous HD cells do not support reduced huntingtin antisense expression due to an expanded CAG repeat. BioMed Central 2015-04-28 /pmc/articles/PMC4411791/ /pubmed/25928884 http://dx.doi.org/10.1186/s13024-015-0018-7 Text en © Evers et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Evers, Melvin M Schut, Menno H Pepers, Barry A Atalar, Melek van Belzen, Martine J Faull, Richard LM Roos, Raymund AC van Roon-Mom, Willeke MC Making (anti-) sense out of huntingtin levels in Huntington disease |
title | Making (anti-) sense out of huntingtin levels in Huntington disease |
title_full | Making (anti-) sense out of huntingtin levels in Huntington disease |
title_fullStr | Making (anti-) sense out of huntingtin levels in Huntington disease |
title_full_unstemmed | Making (anti-) sense out of huntingtin levels in Huntington disease |
title_short | Making (anti-) sense out of huntingtin levels in Huntington disease |
title_sort | making (anti-) sense out of huntingtin levels in huntington disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411791/ https://www.ncbi.nlm.nih.gov/pubmed/25928884 http://dx.doi.org/10.1186/s13024-015-0018-7 |
work_keys_str_mv | AT eversmelvinm makingantisenseoutofhuntingtinlevelsinhuntingtondisease AT schutmennoh makingantisenseoutofhuntingtinlevelsinhuntingtondisease AT pepersbarrya makingantisenseoutofhuntingtinlevelsinhuntingtondisease AT atalarmelek makingantisenseoutofhuntingtinlevelsinhuntingtondisease AT vanbelzenmartinej makingantisenseoutofhuntingtinlevelsinhuntingtondisease AT faullrichardlm makingantisenseoutofhuntingtinlevelsinhuntingtondisease AT roosraymundac makingantisenseoutofhuntingtinlevelsinhuntingtondisease AT vanroonmomwillekemc makingantisenseoutofhuntingtinlevelsinhuntingtondisease |